About Us
Osteoboost is a wearable medical device that delivers precision vibration therapy to the spine and hips - areas most at risk of fractures. A connected app features science-backed exercise and more, delivering a comprehensive 360° treatment. Over 64 million people are at risk for fractures due to low bone density, and Osteoboost is a beacon of hope to help them live stronger, more active lives.
Founders Bio
Osteoboost CEO Laura Yecies is a healthtech leader and strategist with deep experience launching and scaling medical device and diagnostic companies. Prior to Osteoboost, she was CEO of NeuroSync, Catch (acq. by Apple), and SugarSync. She holds an MBA from Harvard, MSFS from Georgetown, and AB from Dartmouth. Yecies is a highly-regarded speaker, podcaster, and writer on healthcare and technology.
Origin Story
Osteoboost's patented technology was inspired by NASA-funded technology, developed to protect astronauts from the effects of zero-gravity on bone density. Following a randomized, double-blind clinical trial at the University of Nebraska Medical Center, Osteoboost was cleared by the FDA in 2024 and granted a Class 2 a De Novo Breakthrough Device designation.